1. A case of maxillary sarcoma in a chimpanzee (Pan troglodytes). Issue 2 (5th December 2013) Authors: Fujisawa, M.; Udono, T.; Nogami, E.; Hirosawa, M.; Morimura, N.; Saito, A.; Seres, M.; Teramoto, M.; Nagano, K.; Mori, Y.; Uesaka, H.; Nasu, K.; Tomonaga, M.; Idani, G.; Hirata, S.; Tsuruyama, T.; Matsubayashi, K. Journal: Journal of medical primatology Issue: Volume 43:Issue 2(2014) Page Start: 111 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AB0415 A New Prognostic Factor to Sustain Remission for 2 Years after Adalimumab Discontinuation & the Clinical Outcomes in RA Patients: Honor Study 2-Years Results. (10th June 2014) Authors: Tanaka, Y.; Hirata, S.; Kubo, S.; Fukuyo, S.; Hanami, K.; Sawamukai, N.; Nakano, K.; Nakayamada, S.; Yamaoka, K.; Saito, K. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 944 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. AB0452 PREDICTIVE FACTORS FOR INSUFFICIENT RESPONSE TO INITIAL TREATMENT OR RECURRENCE IN PATIENTS WITH LUPUS ENTERITIS. (2nd June 2020) Authors: Yoshida, Y.; Sugimoto, T.; Kohno, H.; Watanabe, H.; Mokuda, S.; Hirata, S.; Sugiyama, E. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 1524 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. AB0498 Optimisation of methotrexate dose induced successful reduction of glucocorticoids without impaired disease control in patients with rheumatoid arthritis. (12th June 2018) Authors: Hirata, S.; Kondo, T.; Yukawa, K.; Tokunaga, T.; Kuranobu, T.; Oi, K.; Yoshida, Y.; Funaki, M.; Oda, K.; Nojima, T.; Sugiyama, E. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 1409 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. AB0513 Treatment Strategy Targeting Structural Remission in Patients with Early Rheumatoid Arthritis: A Multi-Central, Prospective, Comparative Study Targeting Joint Damage to Zero (Zero-J Study). (9th June 2015) Authors: Tanaka, Y.; Hirata, S.; Amano, K.; Atsumi, T.; Yamamoto, K.; Sumida, T.; Takeuchi, T.; Kohsaka, H.; Mimori, T.; Kawakami, A.; Nishimoto, N.; Tanaka, E.; Kaneko, Y.; Yasuoka, H.; Fukuyo, S.; Saito, K. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 1070 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. AB0612 SHORT-TERM REVERSIBLE IMPROVEMENT IN EARLY-PHASE ELEMENTS OF NAILFOLD CAPILLARY ABNORMALITIES IN PATIENTS WITH SYSTEMIC SCLEROSIS BY INTRAVENOUS CYCLOPHOSPHAMIDE (IVCY). (2nd June 2020) Authors: Sugimoto, T.; Hirata, S.; Kohno, H.; Watanabe, H.; Yoshida, Y.; Mokuda, S.; Sugiyama, E. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 1602 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. AB0671 Degradation of Isomerized Type II Collagen May Serve as A Discriminative Biomarker of Inflammation Mediated Joint Destruction in Rheumatic Diseases. (15th July 2016) Authors: Thudium, C.S.; He, Y.; Gudmann, N.S.; De Vlam, K.; Lories, R.; Hirata, S.; Tanaka, Y.; Karsdal, M.A.; Bay-Jensen, A.-C. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 1134 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Degradation of isomerized type II collagen – A highly specific marker for joint destruction that can distinguish between different rheumatic pathologies. (April 2016) Authors: Thudium, C.S.; He, Y.; Gudmann, N.S.; Hirata, S.; Petersen, K.K.; Arendt-Nielsen, L.; Lories, R.J.; Simonsen, O.; de Vlam, K.; Tanaka, Y.; Karsdal, M.; Bay-Jensen, A.C. Journal: Osteoarthritis and cartilage Issue: Volume 24(2016)Supplement 1 Page Start: S75 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. FRI0013 Anti-IL-6 autoantibody inhibited elevation of serum C-reactive protein level in two patients with severe bacterial infection. (23rd January 2014) Authors: Nanki, T.; Onoue, I.; Nagasaka, K.; Hirata, S.; Hosoya, T.; Ebisawa, M.; Sugihara, T.; Harigai, M.; Miyasaka, N. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 314 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. FRI0066 Behavior of the multi-biomarker disease activity (vectra da algorithm) score and components in patients with rheumatoid arthritis treated with tocilizumab. (23rd January 2014) Authors: Hanami, K.; Hirata, S.; Tasaka, H.; Li, W.; Bolce, R.; Sasso, E. H.; Defranoux, N. A.; Yamaoka, K.; Saito, K.; Tanaka, Y. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A391 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗